- Home
- ATAI vs HYI Comparison
ATAI vs HYI Comparison
Compare ATAI & HYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- HYI
- Stock Information
- Founded
- ATAI 2018
- HYI 2010
- Country
- ATAI Germany
- HYI United States
- Employees
- ATAI N/A
- HYI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- HYI Investment Managers
- Sector
- ATAI Health Care
- HYI Finance
- Exchange
- ATAI Nasdaq
- HYI Nasdaq
- Market Cap
- ATAI 271.6M
- HYI 266.3M
- IPO Year
- ATAI 2021
- HYI N/A
- Fundamental
- Price
- ATAI $1.35
- HYI $11.82
- Analyst Decision
- ATAI Strong Buy
- HYI
- Analyst Count
- ATAI 4
- HYI 0
- Target Price
- ATAI $9.00
- HYI N/A
- AVG Volume (30 Days)
- ATAI 2.3M
- HYI 50.6K
- Earning Date
- ATAI 03-17-2025
- HYI 01-01-0001
- Dividend Yield
- ATAI N/A
- HYI 9.59%
- EPS Growth
- ATAI N/A
- HYI N/A
- EPS
- ATAI N/A
- HYI N/A
- Revenue
- ATAI $308,000.00
- HYI N/A
- Revenue This Year
- ATAI $80.07
- HYI N/A
- Revenue Next Year
- ATAI N/A
- HYI N/A
- P/E Ratio
- ATAI N/A
- HYI N/A
- Revenue Growth
- ATAI N/A
- HYI N/A
- 52 Week Low
- ATAI $0.78
- HYI $10.99
- 52 Week High
- ATAI $2.85
- HYI $12.24
- Technical
- Relative Strength Index (RSI)
- ATAI 37.14
- HYI 33.96
- Support Level
- ATAI $1.37
- HYI $11.79
- Resistance Level
- ATAI $1.52
- HYI $11.86
- Average True Range (ATR)
- ATAI 0.13
- HYI 0.08
- MACD
- ATAI -0.03
- HYI -0.03
- Stochastic Oscillator
- ATAI 6.31
- HYI 7.69
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.